Best payment processors for kratom operators in 2026

Kratom underwriting in 2026 is harder than it was in 2023. Visa and Mastercard added kratom to their enhanced-review lists following state-level AKA regulation debates. Several acquirers who accepted kratom in 2023 quietly exited the vertical after elevated chargeback trends. The pool of viable processors is narrower than for CBD or even SARMs, but it exists.

Who will not process kratom

Stripe, Square, PayPal, Braintree, Shopify Payments, Adyen, Authorize.net direct, all major aggregators. None approve kratom as of 2026. Operators who slip through get closed inside 60-90 days.

Who will process kratom

Specialized high-risk ISOs

• EasyPayDirect — one of the few ISOs that still takes kratom reliably. Rate 4.5-5.5% effective. Reserve 15-20% rolling 180 days.
• Corepay — takes kratom with tight SKU review; rates similar.
• PaymentCloud — accepts kratom with more scrutiny than CBD. See comparison.
• Durango — places kratom with specialty acquirers. See comparison.
• Soar Payments — newer placements for kratom. See comparison.

The pool shrinks every 12 months as acquirers exit. Before signing, confirm the ISO has an active kratom-approved acquirer — not a "we're looking into it" placeholder.

Offshore acquirers

For volume above $250k/month:

• Emerchantpay (EU) — takes US kratom merchants under specific conditions.
• Paynetics (EU) — high-risk specialty.
• Paybilt (CA) — Canadian acquirer with kratom experience.

Alternative rails

• ACH — some kratom operators run 30-50% of volume through ACH checkout via NACHA-approved processors. Lower fraud, slower settlement, no chargeback risk in the card sense.
• Crypto (USDC) — 8-15% conversion rate of card checkout, zero chargebacks, fast settlement.
• Bank wire — for wholesale kratom (B2B), wire is meaningful volume.

Rate and reserve reality

• Effective rate: 4.5-6.0% all-in. Under 4.5% is teaser pricing.
• Reserve: 15-25% rolling, 180-day hold, standard on new accounts. Established operators with 18+ months clean drop to 8-12%.
• Volume cap: $50-200k/month on new accounts typical.
• Chargeback pause: 0.7% monthly ratio is the unofficial pause trigger. Clean operators run well below 0.3%.

The 7-OH and extract problem

Kratom acquirers have split opinions on concentrated extracts (7-OH, MIT) vs. leaf/powder products. Many will approve leaf and powder but decline extracts. Operators carrying both often maintain two merchant accounts — one for approved SKUs, one crypto-only for the extract line.

State restrictions

Kratom is banned in Alabama, Arkansas, Indiana, Rhode Island, Vermont, and Wisconsin (as of 2026). Several other states have 21+ age requirements. Your checkout flow needs:

• State geo-check with blocking (not just warning)
• Age verification (21+ is becoming standard)
• Label compliance per state (AKA GMP marking where relevant)

Failing any of these kills the merchant account fast. Acquirers place test orders.

Multi-brand kratom operators

If you run 3+ kratom brands:

• Separate accounts: 3 underwriting cycles, 3 reserve pools of 15-25% each, 3 chargeback queues.
• Parent account: one underwriting relationship, one consolidated reserve (often lower percentage against aggregate volume), one chargeback team, sub-brand descriptor preservation.

For kratom specifically, the parent-account model also isolates the risk of one brand triggering a SKU re-review that closes all brands. Cross-references still exist — that's concentration risk — but operationally the consolidation wins at 3+ brands. See kratom operator playbook.

What to check before signing

• Current kratom-approved acquirer behind the ISO (not a pending placement)
• List of acceptable product types (leaf, powder, capsules, extracts split)
• State restriction enforcement — are they auditing your geo-block?
• SKU approval process for new products
• Reserve release conditions (180 days at what ratio?)
• Chargeback pause threshold in writing
• Contract term + early termination fee

What not to do

• Don't market therapeutic benefits. Fastest path to FDA warning letter + acquirer closure.
• Don't process restricted-state orders. One caught transaction closes accounts.
• Don't run kratom through a CBD merchant account — even if the acquirer is the same, kratom is a separate underwriting and misrepresentation is grounds for TMF.
• Don't assume a Stripe approval means Stripe will keep you — kratom approvals are usually not known to risk at underwriting.

What to do next

Single-brand under $100k/month: apply to EasyPayDirect + Corepay + PaymentCloud in parallel. Compare real contracts. Accept that rates are structural — no ISO has a magic low-rate kratom program.

Multi-brand (3+ brands): parent-account structure usually compresses 3+ underwriting relationships into one. Our 12-question application tells us whether the portfolio fits.

Already MATCH-listed: MATCH playbook first. Kratom + MATCH narrows options dramatically.